Advertisement
Screener

Bausch & Lomb Corp (BLCO) Business Combination, Acquisition Related Costs

2.8 / 5 stars · 68/120 Roast Me

Bausch & Lomb Corp Business Combination, Acquisition Related Costs

Bausch & Lomb Corp (BLCO) reported Business Combination, Acquisition Related Costs of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-07-29

  • Bausch & Lomb Corp business combination, acquisition related costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Bausch & Lomb Corp business combination, acquisition related costs for the quarter ending 2026-03-31 was $1.00M, a 0.00% change year-over-year.
  • Bausch & Lomb Corp business combination, acquisition related costs for the quarter ending 2025-12-31 was $2.00M, a 100.00% increase year-over-year.
  • Bausch & Lomb Corp business combination, acquisition related costs for the quarter ending 2025-09-30 was $2.00M, a 0.00% change year-over-year.
  • Bausch & Lomb Corp business combination, acquisition related costs for fiscal 2025 was $7.00M, a 75.00% increase from fiscal 2024.
  • Bausch & Lomb Corp business combination, acquisition related costs for fiscal 2024 was $4.00M, a 84.00% decline from fiscal 2023.
  • Bausch & Lomb Corp business combination, acquisition related costs for fiscal 2023 was $25.00M, a 2400.00% increase from fiscal 2022.
  • Bausch & Lomb Corp business combination, acquisition related costs for fiscal 2022 was $1.00M.
Period endBusiness Combination, Acquisition Related Costs 3 monthBusiness Combination, Acquisition Related Costs 6 monthBusiness Combination, Acquisition Related Costs 9 monthBusiness Combination, Acquisition Related Costs 12 month
2026-06-30$0.00
10-Q · filed 2026-07-29
$1.00M
10-Q · filed 2026-07-29
$3.00M
derived: sum of 3 quarters · filed 2026-07-29
$5.00M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$1.00M
10-Q · filed 2026-04-29
$3.00M
derived: sum of 2 quarters · filed 2026-04-29
$5.00M
derived: sum of 3 quarters · filed 2026-04-29
$7.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$4.00M
derived: sum of 2 quarters · filed 2026-02-18
$6.00M
derived: sum of 3 quarters · filed 2026-07-29
$7.00M
10-K · filed 2026-02-18
2025-09-30$2.00M
10-Q · filed 2025-10-29
$4.00M
derived: sum of 2 quarters · filed 2026-07-29
$5.00M
10-Q · filed 2025-10-29
$6.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$2.00M
10-Q · filed 2026-07-29
$3.00M
10-Q · filed 2026-07-29
$4.00M
derived: sum of 3 quarters · filed 2026-07-29
$6.00M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$1.00M
10-Q · filed 2026-04-29
$2.00M
derived: sum of 2 quarters · filed 2026-04-29
$4.00M
derived: sum of 3 quarters · filed 2026-04-29
$5.00M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$3.00M
derived: sum of 2 quarters · filed 2026-02-18
$4.00M
derived: sum of 3 quarters · filed 2026-02-18
$4.00M
10-K · filed 2026-02-18
2024-09-30$2.00M
10-Q · filed 2025-10-29
$3.00M
derived: sum of 2 quarters · filed 2025-10-29
$3.00M
10-Q · filed 2025-10-29
$9.00M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-30$1.00M
10-Q · filed 2025-07-30
$1.00M
10-Q · filed 2025-07-30
$7.00M
derived: sum of 3 quarters · filed 2026-02-18
$23.00M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-31$0.00
10-Q · filed 2025-04-30
$6.00M
derived: sum of 2 quarters · filed 2026-02-18
$22.00M
derived: sum of 3 quarters · filed 2026-02-18
$24.00M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$22.00M
derived: sum of 2 quarters · filed 2026-02-18
$24.00M
derived: sum of 3 quarters · filed 2026-02-18
$25.00M
10-K · filed 2026-02-18
2023-09-30$16.00M
10-Q · filed 2024-10-30
$18.00M
derived: sum of 2 quarters · filed 2024-10-30
$19.00M
10-Q · filed 2024-10-30
$20.00M
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30$2.00M
10-Q · filed 2024-08-01
$3.00M
10-Q · filed 2024-08-01
$4.00M
derived: sum of 3 quarters · filed 2025-02-19
$4.00M
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31$1.00M
10-Q · filed 2024-05-01
$2.00M
derived: sum of 2 quarters · filed 2025-02-19
$2.00M
derived: sum of 3 quarters · filed 2025-02-19
$2.00M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$1.00M
derived: sum of 2 quarters · filed 2025-02-19
$1.00M
derived: sum of 3 quarters · filed 2025-02-19
$1.00M
10-K · filed 2025-02-19
2022-09-30$0.00
10-Q · filed 2023-11-01
$0.00
derived: sum of 2 quarters · filed 2023-11-01
$0.00
10-Q · filed 2023-11-01
2022-06-30$0.00
10-Q · filed 2023-08-02
$0.00
10-Q · filed 2023-08-02
2022-03-31$0.00
10-Q · filed 2023-05-03
2021-12-31$0.00
10-K · filed 2024-02-21
2020-12-31$0.00
10-K · filed 2023-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Warby Parker Inc. (WRBY)United States$2.970B
COOPER COMPANIES, INC. (COO)United States$10.533B24.09
National Vision Holdings, Inc. (EYE)United States$1.297B
STAAR SURGICAL CO (STAA)United States$0.957B362.70
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B